Myrtelle
WAKEFIELD, MA · Biotechnology · 13 employees
Myrtelle Inc. is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases. Our mission is to develop and deliver novel treatments for devastating disorders of the central nervous system, beginning with our lead program, gene therapy treatment for Canavan disease.
Funding history
- Venture - Series Unknown — $16.7M — Jul 2026
- Venture - Series Unknown — $30.5M — Dec 2025
- Venture - Series Unknown — $7.5M — Mar 2025
- Venture - Series Unknown — $6.0M — Jun 2024
- Venture - Series Unknown — $15.7M — Oct 2022
Recent signals
- Jul 02, 2026: Raised $16.7M in Venture - Series Unknown
- Dec 23, 2025: Raised $30.5M in Venture - Series Unknown
- Mar 21, 2025: Raised $7.5M in Venture - Series Unknown
- Jun 10, 2024: Raised $6.0M in Venture - Series Unknown
- Oct 17, 2022: Raised $15.7M in Venture - Series Unknown
- Jul 08, 2021: Raised $13.5M in Venture - Series Unknown
- Jun 24, 2021: Raised $13.5M in Venture - Series Unknown
See plans & pricing → Track Myrtelle’s funding, hiring, and signals — with verified contacts — on Fundz.